MX2023011382A - Metodos y composiciones para mejorar la produccion y secrecion de insulina. - Google Patents

Metodos y composiciones para mejorar la produccion y secrecion de insulina.

Info

Publication number
MX2023011382A
MX2023011382A MX2023011382A MX2023011382A MX2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A MX 2023011382 A MX2023011382 A MX 2023011382A
Authority
MX
Mexico
Prior art keywords
improving insulin
secretion
compositions
methods
insulin production
Prior art date
Application number
MX2023011382A
Other languages
English (en)
Spanish (es)
Inventor
Pedrosa José María López
Cabrera Ricardo Rueda
Manuel Manzano
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2023011382A publication Critical patent/MX2023011382A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2023011382A 2021-03-31 2022-03-31 Metodos y composiciones para mejorar la produccion y secrecion de insulina. MX2023011382A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21382265 2021-03-31
PCT/US2022/022712 WO2022212621A1 (en) 2021-03-31 2022-03-31 Methods and compositions for improving insulin production and secretion

Publications (1)

Publication Number Publication Date
MX2023011382A true MX2023011382A (es) 2023-10-06

Family

ID=75529926

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023011382A MX2023011382A (es) 2021-03-31 2022-03-31 Metodos y composiciones para mejorar la produccion y secrecion de insulina.

Country Status (6)

Country Link
US (1) US20240065997A1 (enExample)
EP (1) EP4312594A1 (enExample)
JP (1) JP2024513816A (enExample)
CA (1) CA3213326A1 (enExample)
MX (1) MX2023011382A (enExample)
WO (1) WO2022212621A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023183767A1 (en) * 2022-03-21 2023-09-28 Abbott Laboratories Methods and compositions for increasing insulin sensitivity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131854B (it) * 1980-06-30 1986-06-25 Baldacci Lab Spa Composizione farmaceutica per uso terapeutico,per uso diagnostico e quale integratore alimentare
JPH0647547B2 (ja) * 1985-03-20 1994-06-22 大塚製薬株式会社 栄養補給飲食品
AU784752B2 (en) * 1999-10-18 2006-06-08 Northern Innovations Holding Corp. Food supplement for increasing lean mass and strength
JP4534579B2 (ja) * 2004-04-28 2010-09-01 味の素株式会社 リジン含有抗肥満または抗高脂血症用食品、飼料またはサプリメント
DK2381784T3 (en) * 2008-12-09 2018-10-22 Metabolic Tech Inc Nutritional intervention to improve muscle function and strength
WO2013148685A1 (en) * 2012-03-26 2013-10-03 Abbott Laboratories Pea protein containing nutritional compositions
WO2014152606A2 (en) * 2013-03-14 2014-09-25 Abbott Laboratories Treatment of insulin resistance associated with prolonged physical inactivity
CN109090454A (zh) * 2018-08-07 2018-12-28 广西弘山堂生物科技有限公司 一种猴菇养胃粉及其制备方法

Also Published As

Publication number Publication date
US20240065997A1 (en) 2024-02-29
WO2022212621A1 (en) 2022-10-06
CA3213326A1 (en) 2022-10-06
JP2024513816A (ja) 2024-03-27
EP4312594A1 (en) 2024-02-07

Similar Documents

Publication Publication Date Title
TN2021000028A1 (en) Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject
MX2025009008A (es) Cepas bacterianas probioticas que producen acidos grasos de cadena corta y composiciones que las comprenden
MX2019010638A (es) Modificadores de sabor para productos analogos de carne.
NZ593145A (en) Compositions with reduced dimer formation
MX2017015037A (es) Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas.
MY207295A (en) Method for preparing a composition comprising cetylated fatty acids
MX2019005466A (es) Composiciones y metodos para tratar diabetes, hipertension e hipercolesterolemia.
AR119472A1 (es) Composiciones y métodos para tratar la cavidad oral
MY173927A (en) Formula fortifier
MX420109B (es) Metodo para producir una composicion inmunogenica
MX2020013988A (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha.
WO2023009759A3 (en) Antibody-drug conjugates and methods of use thereof
WO2013032558A4 (en) Products for anti-inflammation support
MX2023006086A (es) Métodos para prevenir, retrasar o aliviar enfermedades atópicas.
MX2026000276A (es) Composiciones y metodos para tratar la esclerosis multiple
WO2021260067A3 (en) Method for the treatment of protein-containing compositions
WO2021067611A3 (en) Compositions and methods for treating alzheimer's disease
AR117626A1 (es) COMPOSICIÓN QUE COMPRENDE INHIBIDOR DE LA a-1 PROTEINASA ALTAMENTE CONCENTRADO Y PROCEDIMIENTO PARA LA OBTENCIÓN DE LA MISMA
MX2023007791A (es) Metodo para mejorar la salud de las articulaciones mediante la administracion de exosomas derivados de la leche bovina.
PH12017502323A1 (en) Novel xylanase
CR20230257A (es) Ésteres de ácidos dicarboxílicos para el tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa d
MX2021015732A (es) Administracion intranasal de merotocina para mejorar la lactancia.
GEAP202515919A (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof
MX2021005776A (es) Formulaciones farmaceuticas para administracion subcutanea.
ZA202402369B (en) Compositions and methods for treating or preventing inflammatory diseases including diabetes and thyroid diseases